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Abstract 
The association of endometriosis with ovarian cancer has been a rare but well-documented phenomenon since 1925, 
when Sampson first described clear cell carcinoma arising from endometriosis. Here, we report the case of a woman 
who underwent staging laparotomy including total abdominal hysterectomy and bilateral salpingo-oophorectomy 
with the excision of an abdominal wall mass at the site of her cesarean section scar. Although the abdominal wall 
mass and lymph node was proven to be clear cell carcinoma, the patient’s ovaries were free of carcinoma. This case 
provides important etiological evidence because it is a clear example of endometriosis that has transitioned to clear 
cell carcinoma. We report this case for review. 
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1. Introduction 
Endometriosis is a gynecological condition in which endometrial tissue is present outside of the uterus. Affecting 
10-15% of all women of reproductive age [1], endometriosis is among the most common gynecological disorders 
and can cause pain and infertility. Although endometriosis is regarded as a benign disease, associations between 
endometriosis and ovarian cancer have been reported since 1925, when Sampson described the first case of a 
malignant transformation of ovarian endometriosis [2]. We report a case of clear cell carcinoma that arose from 
abdominal wall endometriosis at the site of a cesarean section scar. The case is especially interesting because ovaries 
were free of cancer, but lymph node metastasis was present. We review the relationship between endometriosis and 
clear cell carcinoma. 
Arch Clin Med Case Rep 2019; 3 (6): 494-499    DOI: 10.26502/acmcr.96550126 
Archives of Clinical and Medical Case Reports    495 
2. Case Report 
2.1 General characteristics 
The patient was 50 years old, married, and T2 P0 A4 L2 at presentation. She had a prior history of the following 
operations: cesarean section in 1992 and excision of a soft tissue mass that was identified as endometriosis in 2003. 
She had a family history of hypertension and diabetes mellitus. 
 
2.2 Present illness 
The patient transferred to our institution with metastatic clear cell carcinoma that had been pathologically proven by 
ultrasonography-guided bilateral inguinal lymph node biopsy. She had undergone a cesarean section in 1992 and 
had had a soft tissue mass excised in 2003. The mass was diagnosed as endometriosis in 2003. She was admitted, 
and a baseline study was performed. There were no abnormal finding in complete blood count, urinalysis, chemical 
analysis, electrolyte analysis, chest radiography, and electrocardiography. Of the tumor markers, cancer antigen 
(CA) 125 was slightly elevated (45.4 U/mL, reference range 0–35 U/mL), while CA 19-9 and carcinoembryonic 
antigen were within normal ranges. 
 
2.3 Imaging studies 
Pelvic magnetic resonance imaging (MRI) showed multiple metastatic lymphadenopathy in both inguinal and 
external iliac chains. A mass lesion was found at the right abdominal wall (Figure 1).  
 
 
Figure 1: Pelvic magnetic resonance imaging (MRI) showed multiple metastatic lymphadenopathy in both inguinal 
and external iliac chains. 
 
Positron emission tomography-computed tomography showed a lobulated contour of the uterus with multiple 
myomas. Multiple enlarged lymph nodes were suggestive of malignant lymph nodes. They involved the right 
internal iliac, left external iliac, and bilateral inguinal areas. There was a soft tissue mass with a cystic portion in the 
right anterior abdominal wall (Figure 2). The mass was suspected to be a malignancy. 
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Figure 2: Soft tissue mass with a cystic portion of the right anterior abdominal wall. 
 
2.4 Intraoperative findings 
At the time of the operation, a subcutaneous mass (approximately 5 × 3 cm) was observed on the right side of the 
cesarean section site. The mass was excised and sent to the pathology department. Evaluation indicated clear cell 
carcinoma. After entering the abdominal cavity, the uterus was normal in size and multiple myomas were noted. 
Both ovaries and fallopian tubes were normal in gross appearance. Metastatic clear cell carcinoma was proven by 
inguinal lymph node biopsy.  
 
Accordingly, ovarian clear cell carcinoma was suspected and we decided to perform a staging laparotomy, including 
total abdominal hysterectomy, bilateral salpingo-oophorectomy, bilateral pelvic lymph node dissection, total 
omentectomy, incidental appendectomy, and paraaortic lymphadenectomy. Severe utero-rectosigmoidal adhesion 
was present and a mass-like lesion (2 × 2 cm) was noted in the colon. Low anterior resection was performed by the 
department of general surgery. A mesh was applied to the right abdominal wall to cover a fascial defect due to the 
abdominal wall mass excision.  
 
2.5 Pathology 
On pathologic examination, both ovaries were free of carcinoma. Only an endometriotic cyst and endometriosis 
were noted. Nonetheless, metastasis was observed in 3 of 14 regional lymph nodes. Soft tissue from the abdominal 
mass excision was proven to be clear cell adenocarcinoma associated with endometriosis. Endometriosis was noted 
at the site of the lower anterior resection. Adenomyosis in the deep myometrium, leiomyoma, and a left paratubal 
cyst were also noted (Figure 3). 
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Figure 3: A. Ovary: Endometriotic cyst, x100; B. Lymph node, inguinal: Metastatic adenocarcinoma, x200; C. 
Lymph node, inguinal: Metastatic adenocarcinoma, cytokeratin x100; D. Soft tissue, abdominal mass, excision: 
Clear cell adenocarcinoma, associated with endometriosis, x100. 
 
2.6 Postoperative status  
The patient was discharged five days after surgery. She received adjuvant chemotherapy with paclitaxel and 
carboplatin. Because of postoperative wound dehiscence, the patient received continuous dressing, debridement, and 
coverage with rectus muscle flap transposition, performed by the plastic surgery department. After the sixth cycle of 
postoperative adjuvant chemotherapy, a positron emission tomography-computed tomography scan was performed. 
The bilateral inguinal lymph nodes had decreased in size. However, we observed persistent 18F-fluorodeoxyglucose 
(FDG) uptake, which was suggestive of a residual viable lesion. Further, we observed an enlarged left iliac lymph 
node with intense FDG uptake, suggestive of malignant lymph node status. Palliative tomotherapy was performed 
on the left iliac, bilateral, and inguinal lymph nodes. 
 
After the ninth cycle of postoperative adjuvant chemotherapy, a second-look laparoscopy was performed with 
bilateral inguinal lymph node dissection. Pathology indicated metastatic adenocarcinoma. An APCT was performed 
15 months after operation. Multiple liver metastases were observed and increased size of the paraaortic, aortocaval, 
bilateral iliac chain, and mesenteric lymph nodes. The patient expired 17 months after operation. 
 
3. Discussion 
The association of endometriosis with ovarian cancer has been a rare but well-documented phenomenon since 1925, 
when Sampson established the first histopathological criteria. To demonstrate that endometriosis has transformed 
into malignancy, several criteria have been recommended [2]. The natural history of ovarian cancer, its 
pathogenesis, and the origin of precursor cells are poorly understood. Recently, a novel theory of ovarian carcinoma 
progression has been proposed [3]. According to this model, surface epithelial tumors can be clinicopathologically 
and genetically divided into 2 categories that correspond to pathways of tumorigenesis. The transformation of 
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endometriosis to cancer can be classified as follows: transformation to ovarian clear cell carcinoma at the ovary, to 
extragonadal clear cell carcinoma, or to other extragonadal carcinoma. Studying 222 malignant tumors originating 
from endometriosis, Irvin and Perkey found 169 ovarian and 53 extragonadal cases [4]. The most common site of 
transformation is the ovary, but extragonadal transformation has been observed at the rectovaginal septum, pelvic 
peritoneum, uterine ligament, vagina, and colorectal serosa [5]. 
 
In this case, endometriosis transformed into extragonadal clear cell carcinoma. The malignant transformation of 
endometriosis within surgical scars is rare [6]. Clear cell carcinoma originating from endometriosis in the abdominal 
wall and whose ovary was free of carcinoma is an especially rare phenomenon. Scar endometriosis can theoretically 
occur at any pelvic surgical site. It has been reported to occur in up to 1% of cesarean section scars [7]. Scar 
endometriosis results from iatrogenic transplantation of endometrial tissue during delivery or gynecologic surgery, 
rather than a metaplastic phenomenon [8]. 
 
Because of its rarity, there is no standard treatment strategy for clear cell carcinoma of the abdominal wall. 
Complete surgical excision with normal margins has a 0–15% tumor recurrence rate in the first year. In our case, the 
tumor was localized and resectable according to the preoperative evaluation. Complete surgical excision was 
important to remove the tumor, diagnose clear cell carcinoma, and prevent recurrence. The 5-year survival rate of 
patients with malignant transformation of endometriosis in the abdominal wall varies from 10% to 100%, depending 
on the histologic type and disease localization [9]. Because the malignant transformation of endometriosis is rare, 
the optimal treatment remains unknown. Treatment with chemotherapy, radiotherapy, and progestin therapy have 
been proposed, but their efficacies remain unclear [10, 11].  
 
In summary, we have described clinical scenarios of abdominal wall clear cell carcinoma with surgical and adjuvant 
chemotherapy treatment. We have reported the rare case of a patient who had clear cell carcinoma at a cesarean 
section scar site, but whose ovaries were free of cancer.  
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